Overall, these data indicate that circ-HIPK3 promotes glioma progression by targeting miR-654 from IGF2BP3, implying that circ-HIPK3 may be a therapeutic target for glioma [93] (Figure 3 and Table 2). The gene discussed is IGF2BP3; the disease is central nervous system cancer.